| Name | chromosome 2 open reading frame 92 |
| Description | Predicted to be located in membrane. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe collection of studies provided offers insights into diverse cellular processes related to metabolic regulation and tumor biology. For instance, one study examined the mechanisms governing insulin‐stimulated GLUT4 translocation in adipocytes, revealing a critical role for TBC1D13 in modulating Rab GTPases—especially implicating Rab35 in the regulation of glucose transporter trafficking. However, this work did not address any functional role for C2orf92 in these molecular events."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n \nDisparate from the insulin‐signaling investigation, a pair of studies focused on the long non‑coding RNA LINC01125 in different cancer settings. One study identified serum exosomal LINC01125 as a potential diagnostic and prognostic biomarker for non‑small cell lung cancer (NSCLC), as well as demonstrating its involvement in regulating tumor growth and metastasis. A related study further explored the role of LINC01125 in papillary thyroid cancer, highlighting its anti‑tumor properties and the contributions of N6‑methyladenosine (m6A) modification in its mechanism of action. Similar to the metabolic study, these cancer‐focused investigations did not mention or implicate C2orf92 in their experimental findings."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": "\n \nCollectively, while these abstracts substantially advance our understanding of insulin‐mediated glucose transport and the oncogenic processes associated with LINC01125, they do not provide any direct evidence or functional insights regarding C2orf92. Future research will be needed to delineate whether C2orf92 participates in any of these pathways or regulates distinct biological processes.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jonathan R Davey, Sean J Humphrey, Jagath R Junutula, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TBC1D13 is a RAB35 specific GAP that plays an important role in GLUT4 trafficking in adipocytes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Traffic (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1600-0854.2012.01397.x"}], "href": "https://doi.org/10.1111/j.1600-0854.2012.01397.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22762500"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22762500"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Jianfeng Xian, Yuyuan Zeng, Shizhen Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Discovery of a novel linc01125 isoform in serum exosomes as a promising biomarker for NSCLC diagnosis and survival assessment."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Carcinogenesis (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/carcin/bgab034"}], "href": "https://doi.org/10.1093/carcin/bgab034"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33928340"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33928340"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Tianyou He, Hailiang Xia, Baojie Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "m6A Writer METTL3-Mediated lncRNA LINC01125 Prevents the Malignancy of Papillary Thyroid Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Crit Rev Immunol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1615/CritRevImmunol.2023050267"}], "href": "https://doi.org/10.1615/CritRevImmunol.2023050267"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37824376"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37824376"}]}]}]}
|
| NCBI Gene ID | 728537 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
C2ORF92 has 383 functional associations with biological entities spanning 5 categories (disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 13 datasets.
Click the + buttons to view associations for C2ORF92 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of C2ORF92 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CellMarker Gene-Cell Type Associations | cell types associated with C2ORF92 gene from the CellMarker Gene-Cell Type Associations dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of C2ORF92 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| DISEASES Experimental Gene-Disease Association Evidence Scores 2025 | diseases associated with C2ORF92 gene in GWAS datasets from the DISEASES Experimental Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with C2ORF92 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of C2ORF92 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of C2ORF92 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of C2ORF92 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of C2ORF92 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of C2ORF92 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of C2ORF92 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of C2ORF92 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| Tahoe Therapeutics Tahoe 100M Perturbation Atlas | drug perturbations changing expression of C2ORF92 gene from the Tahoe Therapeutics Tahoe 100M Perturbation Atlas dataset. | |